218 related articles for article (PubMed ID: 34743823)
21. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
22. Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer.
Id Said B; Chen H; Jerzak KJ; Warner E; Myrehaug S; Tseng CL; Detsky J; Husain Z; Sahgal A; Soliman H
J Neurooncol; 2022 Aug; 159(1):177-183. PubMed ID: 35715667
[TBL] [Abstract][Full Text] [Related]
23. Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases.
Cheok SK; Yu C; Feng JJ; Briggs RG; Chow F; Hwang L; Ye JC; Attenello FJ; Tran D; Chang E; Zada G
Neurosurg Focus; 2023 Aug; 55(2):E9. PubMed ID: 37527673
[TBL] [Abstract][Full Text] [Related]
24. Reirradiation With Stereotactic Radiosurgery After Local or Marginal Recurrence of Brain Metastases From Previous Radiosurgery.
Kowalchuk RO; Niranjan A; Lee CC; Yang HC; Liscak R; Guseynova K; Tripathi M; Kumar N; Peker S; Samanci Y; Hess J; Chiang V; Iorio-Morin C; Mathieu D; Pikis S; Wei Z; Lunsford LD; Trifiletti DM; Sheehan JP
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):726-734. PubMed ID: 34644606
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
[TBL] [Abstract][Full Text] [Related]
26. Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact intracranial metastases.
Zhang Q; Hamilton D; Conway P; Xie SJ; Haghighi N; Lasocki A
J Med Imaging Radiat Oncol; 2023 Apr; 67(3):308-319. PubMed ID: 36847751
[TBL] [Abstract][Full Text] [Related]
27. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
[TBL] [Abstract][Full Text] [Related]
28. Radiation Necrosis from Stereotactic Radiosurgery-How Do We Mitigate?
Vellayappan BA; McGranahan T; Graber J; Taylor L; Venur V; Ellenbogen R; Sloan AE; Redmond KJ; Foote M; Chao ST; Suh JH; Chang EL; Sahgal A; Lo SS
Curr Treat Options Oncol; 2021 Jun; 22(7):57. PubMed ID: 34097171
[TBL] [Abstract][Full Text] [Related]
29. Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non-small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review.
Zhou F; Jiang L; Sun X; Wang Z; Feng J; Liu M; Ma Z
APMIS; 2024 Jun; 132(6):375-381. PubMed ID: 38466886
[TBL] [Abstract][Full Text] [Related]
30. Cumulative Intracranial Tumor Volume and Number of Brain Metastasis as Predictors of Developing New Lesions After Stereotactic Radiosurgery for Brain Metastasis.
Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM
World Neurosurg; 2017 Oct; 106():666-675. PubMed ID: 28735139
[TBL] [Abstract][Full Text] [Related]
31. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
[TBL] [Abstract][Full Text] [Related]
32. The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.
Mayo ZS; Billena C; Suh JH; Lo SS; Chao ST
Neuro Oncol; 2024 Mar; 26(12 Suppl 2):S56-S65. PubMed ID: 38437665
[TBL] [Abstract][Full Text] [Related]
33. Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response.
Sayan M; Mustafayev TZ; Balmuk A; Mamidanna S; Kefelioglu ESS; Gungor G; Chundury A; Ohri N; Karaarslan E; Ozyar E; Atalar B
Radiat Oncol J; 2020 Sep; 38(3):176-180. PubMed ID: 33012145
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases.
Andruska N; Kennedy WR; Bonestroo L; Anderson R; Huang Y; Robinson CG; Abraham C; Tsien C; Knutson N; Rich KM; Spencer C; Huang J
Radiother Oncol; 2021 Mar; 156():181-187. PubMed ID: 33310010
[TBL] [Abstract][Full Text] [Related]
35. Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.
Narloch JL; Farber SH; Sammons S; McSherry F; Herndon JE; Hoang JK; Yin FF; Sampson JH; Fecci PE; Blackwell KL; Kirkpatrick JP; Kim GJ
Neuro Oncol; 2017 Oct; 19(10):1391-1397. PubMed ID: 28472527
[TBL] [Abstract][Full Text] [Related]
36. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
37. BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis.
Patel KR; Chowdhary M; Switchenko JM; Kudchadkar R; Lawson DH; Cassidy RJ; Prabhu RS; Khan MK
Melanoma Res; 2016 Aug; 26(4):387-94. PubMed ID: 27223498
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1-3 cerebral metastases.
Schüttrumpf LH; Niyazi M; Nachbichler SB; Manapov F; Jansen N; Siefert A; Belka C
Radiat Oncol; 2014 May; 9():105. PubMed ID: 24885624
[TBL] [Abstract][Full Text] [Related]
39. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
Lehrer EJ; Khosla AA; Ozair A; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Mathieu D; Trudel C; Deibert CP; Malouff TD; Ruiz-Garcia H; Peterson JL; Patel S; Bonney P; Hwang L; Yu C; Zada G; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Fakhoury KR; Rusthoven CG; Dickstein DR; Sheehan JP; Trifiletti DM; Ahluwalia MS
J Neurooncol; 2023 Oct; 165(1):63-77. PubMed ID: 37889444
[TBL] [Abstract][Full Text] [Related]
40. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
Miller JA; Bennett EE; Xiao R; Kotecha R; Chao ST; Vogelbaum MA; Barnett GH; Angelov L; Murphy ES; Yu JS; Ahluwalia MS; Suh JH; Mohammadi AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1060-1069. PubMed ID: 27742540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]